Tesamorelin plus exercise: understanding the TRIUMPH trial protocol in older adults with HIV
What was published here is a trial protocol. It describes how a study is being planned, not an effect that has already…
Read source review →Peptides acting on the growth hormone / IGF-1 axis fall into two broad groups: GHRH analogues that act on the pituitary GHRH receptor, and ghrelin-mimetic secretagogues acting on GHS-R1a.
This section also covers IGF-1 variants and the modified-release analogues used where a longer half-life is required.
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 1–6 of 27 reviewed articles · Page 1 of 5
What was published here is a trial protocol. It describes how a study is being planned, not an effect that has already…
Read source review →A small trial looked at the relationship between tesamorelin and cognition and brain connectivity. The main measures found no clear improvement, but…
Read source review →An early human experiment measured a brief change in ejection fraction. Understand the result without turning it into a heart-treatment claim.
Read source review →A CT scan can tell researchers about the amount of abdominal fat and a separate property called attenuation. Those measurements are different.…
Read source review →“Selective” sounds reassuring, but it describes a particular experimental comparison. The original ipamorelin pharmacology paper tested growth-hormone release and several other hormones…
Read source review →“PEG-MGF” is not a complete molecular identity. A defensible material record must define the peptide, PEG architecture, attachment chemistry, site distribution and…
Read source review →If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.